CompanyDrug

Sino Biopharmaceutical Receives NMPA Approval for Biosimilar Herceptin for HER2+ Cancers

Policy / Regulatory

CDE Launches Technical Guidelines to Emphasize Patient-Centered Drug Clinical Trials

CompanyDrug

Eli Lilly’s Donanemab Shows Significant Slowdown in Alzheimer’s Disease Progression in Phase III Study

CompanyDrug

Jiangsu Simcere Pharmaceutical Receives NMPA Approval for Atopic Dermatitis Drug SIM0278

CompanyDeals

Pingshan District and Fosun Pharma Ink Strategic Deal to Boost Biomedical Industry

CompanyDrug

CanSino Biotechnology Receives NMPA Approval for Tetanus Vaccine CS-2047

CompanyDeals

SanReno Therapeutics Partners with WuXi STA for Comprehensive R&D and Manufacturing Services

CompanyDeals

Chongqing Zhifei Biological Partners with PT Bio Farma for Global Tuberculosis Vaccine Development

CompanyDrug

BRL Medicine Inc. Receives IND Approval for CD19-Targeted CAR-T Therapy BRL-301 from CDE

Company

Bristol-Myers Squibb Q2 2023 Results Miss Estimates, Full-Year Guidance Revised Downward

Company

Pfizer Announces Leadership Shake-Up with Focus on Oncology R&D

Company

Roche Group’s H1 2023 Financial Report: Pharmaceuticals Grow While Diagnostics Dip